Abstract. Granulation tissue fibroblasts (myofibroblasts) develop several ultrastructural and biochemical features of smooth muscle (SM) cells, including the presence of microfilament bundles and the expression of a-SM actin, the actin isoform typical of vascular SM cells. Myofibroblasts have been proposed to play a role in wound contraction and in retractile phenomena observed during fibrotic diseases. We show here that the subcutaneous administration of transforming growth factor-ill (TGFfll) to rats results in the formation of a granulation tissue in which a-SM actin expressing myofibroblasts are particularly abundant. Other cytokines and growth factors, such as platelet-derived growth factor and tumor necrosis factor-a, despite their profibrotic activity, do not induce a-SM actin in myofibroblasts. In situ hybridization with an a-SM actin probe shows a high level of ot-SM actin mRNA expression in myofibmblasts of TGFBl-induced granulation tissue. Moreover, TGFfll induces cz-SM actin protein and mRNA expression in growing and quiescent cultured fibroblasts and preincubation of culture medium containing whole blood serum with neutralizing antibodies to TGFfll results in a decrease of a-SM actin expression by fibmblasts in replicative and nonreplicative conditions. These results suggest that TGFfll plays an important role in myofibroblast differentiation during wound healing and fibrocontractive diseases by regulating the expression of ot-SM actin in these cells.
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RANULATION tiSSUe formation and contraction are critical steps for the healing of an open wound (for review see Skalli and Gabbiani, 1988) . These processes are characterized by the involvement of a specialized mesenchymal cell with morphologic and biochemical featares between those of the fibroblast and of the smooth muscle (SM) ~ cell, called myofibroblast (Gabbiani et al., 1971 ; and for review see Schiirch et al., 1992) . Myofibroblasts disappear in normal scars, but persist in hypertrophic scars and in fibrotic lesions of many organs, including stroma reaction to epithelial tumors (Dvorak, 1986; Skalli et al., 1989b; Sappino et al., 1990b; Kuhn and McDonald, 1991; Gressner and Meyer, 1992) , where they are allegedly involved in retractile phenomena as well as in extracellular matrix accumulation (Gabbiani et al., 1976; Bazin et al., 1980; Gressner and Meyer, 1992 ; and for review see Schiirch et al., 1992) . The hallmark of the myofibroblastic phenotype is the expression of ot-SM actin (Skalli et al., 1989b; Darby et al., 1990) , the actin isoform present in SM cells and myoepithe-lial cells, and particularly abundant in vascular SM cells (Rubenstein, 1990; McHugh et al., 1991) . Many aspects of myofibroblast biology are still mysterious, such as the factors regulating the expression of ot-SM actin by these cells. Previous work from our laboratory has shown that growth factors known to elicit fibroblast replication in vivo and in vitroe.g., PDGF or tumor necrosis factor-ix (TNFo0-do not induce a-SM actin expression by these cells Desmouli~re et al., 1992b ). Here we report that the local administration of transforming growth factor-ill (TGFfll) in vivo results in the formation of a granulation tissue in which ot-SM actin expressing myofibroblasts are particularly abundant. Moreover, TGFfll induces tx-SM actin expression in growing and quiescent cultured fibroblasts and neutralizing antibodies to TGFfll inhibit partly the expression of o~-SM actin in fibroblasts cultured in the presence ofanimals per group were used. Osmotic minipumps (model 2001; Alza Corp., Palo Alto, CA) were filled under sterile conditions with TGFB1 isolated from hnman platelets (Sigma Immnnochemicals, St. Louis, MO; and a gift of Dr. A. B. Roberts, Laboratory of Chemoprevention, National Cancer Institute, Bethesda, MD), or recombinant-human "I'GF~I (gift of Dr. A. B. Roberts). Recombinant muriue TNFtx (gift of Dr. G. Grau, Department of Pathology, University of Geneva, Geneva, Switzerland, with an endotoxin contamination <1 ng/ml, Grau et ai., 1987; Piguet et al., 1990 ) was used. Minipumps were implanted subcutaneously into the back of the animals, through a channel (,,o3-cm long) prepared immediately before with blunt sterile scissors. Incisions were always performed over the sacral region. In controls, the pumps were filled with carder solution. Pump outlets were oriented cranially. After 7 d of continuous delivery, the pumps were removed and their content verified. Animals in which the pumps were not empty were discarded. Newly formed granulation tissues surrounding perfusion pumps were collected systematically in the region close to the outlet and in the middle of the pump; they were either frozen in liquid isopentane immersed in liquid nitrogen and stored at -80"C for indirect immunofluorescence and for biochemical studies or fixed for light and EM.
Drugs were delivered at the following doses per day: 'I'GFB1, 140 rig; TNFa, 1 #g (Desmouli~re et al., 1992b) . The substances were brought to final concentration in sterile 150 mM NaCI just before implantation.
Cells and Culture Conditions
Cells were cultured in MEM (Gibco AG, Basel, Switzerland) supplemented with 100 U/ml penicillin, 100/zg/ml streptomycin and 2 mM L-glutamine, and containing 10% FCS (Gibeo AG). Rat and human PDS and WBS were prepared according to Vogel et al. (1978) . Cultures were incubated at 370C in a humidified atmosphere of 5% COz/95% air with medium changes twice a week.
Rat fibroblasts were obtained from explants of subcutaneous tissue of the back. Human fibroblasts were obtained from explants of normal subcutaneous tissue of breast skin from women undergoing reduction mammoplasty for cosmetic reasons. We have also used the HFL-1 cell line derived from human embryo lung (American Type Culture Collection, Rockville, MD) and bovine aortic endothelial cells .
Passage 5 cells were treated with TGF/31 in different culture conditions. In most cases, doses between 5 and 10 ng/ml which has been shown to induce c~-SM actin in human arterial SM cells (Bj6rkerud, 1991) were used. Medium was removed 24 h after plating and fibroblasts were incubated for 7 d with MEM plus serum alone or supplemented with TGF/31. To study TGF/31 effects on growth-arrested cells, the cytokine was added for 7 d to cultures where FCS had been substituted with 10% PDS and in which no growth was observed (Desmouli~re et al., 1992b) , or to a confluent monolayer of fibroblasts. The cell number was determined by performing haemocytometer cell count. A total of seven experiments were done using cell populations from different donors.
To neutralize the activity of TGF~, chicken (IgY; Research & Diagnostic Systems, Inc., Minneapolis, MN) or turkey (gift of Dr. A. B. Flanders et ai., 1988) neutralizing antibodies to TGFBI (1-15 t~g/ml) were added to the culture medium and incubated for 1 h at room temperature. As a control, the same protein concentration of immnnoglobulins from nonimmunized chickens or turkeys was used.
Immunofluorescence Staining
Double immnnofluorescence was performed using anti-c~SM-1, a mouse mAb specific for c~-SM actin (Skulli et al., 1986) and either a rabbit polyclonal anti-actin antibody recognizing all actin isoforms (Skalli et al., 1986) , an affinity-purified rabbit polyclonal anti-SM myosin antibody (Benzonana et al., 1988) or an affinity-purified rabbit polyclonal anti-desmin antibody (Kocher et al., 1984) . TRITC-labeled goat anti-mouse Ig (Nordic Immunological Laboratories, Tllburg, The Netherlands) and diehlorotriazinyl amino fluorescein (DTAF)-conjugated goat anti-rabbit IgG (Jackson ImrnunoResearch Labs, Inc., West Grove, PA) were used for the second step. To minimize cross reactions, second antibodies were passed on solid immnnoabsorbants of rat serum cross-linked with glutaraldehyde. Control staining was performed using non-immune IgGs at the same dilution used for the primary antibody. After washing, preparations were mounted and observed on a Zeiss Axiophot microscope (Carl Zeiss, Oberkechen, FRG) equipped with epiillumination and specific filters for rhodamine and fluorescein (Carl Zeiss). Photographs were taken, using Plan Neofluar 40×/0.90 objective, on T-Max Kodak black and white film (Eastman Kodak, Rochester, NY).
Cells were fixed in methanol for 5 rain at -20°C. Immnnolluorescence was performed in culture dishes or on cells detached by trypsinization and cytocentrifuged at 125 g for 5 rain (Shandon Scientific-Co., London, UK). Cell counts were performed using the interactive image analysis system VIDAS (Kontron Elektronik GmbH, Eching, FRG) connected to an Intensified CCD camera type FMC-4005 (AVT-Horn, Aalan, FRG).
Cryostat sections (3-4-/~m thick) of tissue samples were fixed in acetone at -200C for 5 rain and air dried at room temperature for 2 h. Adjacent frozen sections were stained with hematoxylin and eosin in order to correlate histologic with immunohistochemical evaluations.
In Situ Hybridization
A 33-met synthetic oligonucleotide (dTAGCACACAACTGTGAATGTTTT-GTGGATCAGC-OH) derived from the rat c~-SM actin 3'-untranslated region was used as single-stranded template (Bochaton-Piallat et al., 1992 ). An ll-mer synthetic oligonucleotide (dATCCACAAAAC-OH) was used as primer and extended by means of Klenov fragment of DNA polymerase I (sp act >3,000 U/rag; Boehringer Mannheim GbmH, Mannheim, FRG) with deoxyribonucleotide triphosphates (except dCTP) and 32p-labeled dCTP (sp act >3,000 Ci/mM; Amersham Corp., Arlington Heights, IL) according to Sambrook et al. (1989) . The labeled oligonucleotide (29 mer) was run on a 12% polyacrylamide sequencing gel with 7 M urea (Bio-Rad Laboratories AG, Glattbrugg, Switzerland). After gel autoradiography, the band was located, cut out, and eluted overnight in sterile distilled water with shaking.
Cryostat sections (3--4-t~m thick) of tissue samples were deposited on slides pretreated with 3-aminopropyl-triethoxysilane (Flulm Chemic AG, Buchs, Switzerland), fixed in 4% paraformaldehyde (Merck, Darmstadt, FRO at 4°C for 20 min, dehydrated, and stored at -80*(2 until use. The sections were incubated in 0.25 % acetic anhydride (Fluka Chemie AG) in 0.1 M triethanolamine-HCl, pH 8.0 (Flulm Chemic AG), for 10 rain, and then prehybridized in 50% deionized formamide (Flulm Chemia AG), 30 mM phosphate buffer, 0.02 % Denhardt's solution (Sambrook et ai., 1989), 1 mg/ml denatured salmon sperm DNA (Sigma Chemical Co.), 0.6 M NaC1, and 5 mM EDTA (Fhika Chemic AG) at 30"C for 4 h. Hybridization was performed in the same solution with the labeled oligonucleotide at 30"C overnight. Slides were washed in 2x SSC (SSC is 0.15 M NaCl, 0.015 M sodium citrate) for 1 min at room temperature, and then in Ix SSC at 40"C with shaking for 1 h and rinsed in ethanol. Slides were dipped into NTB2 autoradiographic emulsion (Eastman Kodak) and stored at 4"C. Preparations were observed on a Zeiss Axiophot microscope. Photographs were taken, using Plan Neoflnar 40×/0.90 objective, on Ektachrome 64T color film. Densitometric evaluation of labeling was performed using the interactive image analysis system VIDAS (Kontron Elektronik GmbH) connected to an Intensified CCD camera type FMC-4005 (AVT-Horn).
Light and Electron Microscopy
For light microscopy, tissue samples were fixed in ethanol and embedded in paraffin wax. Sections (5-#m thick) were cut and stained with hematoxylin and eosin, or with Van Gieson (for collagen)-elnstin.
For EM, tissues were cut in small cubes, fixed 4 h at room temperature in 2% glntaraldehyde (Merck, Darmstadt, FRO) in 0.1 M cacodylate (Merck) buffer and stored in buffer overnight at 4°C. They were postfixed in 2 % OsO4 (Merck), dehydrated in graded ethanols, and embedded in Epon 812 (Fluka Chemie AG, Buchs, Switzerland). Semithin sections were cut arid stained with methylene blue. Representative areas were selected for thin sections. These were collected on copper grids, double stained with uranyl acetate (Merck) and lead citrate (Merck), and examined with a Philips 400 electron microscope.
For immunoelectron microscopy, specimens were cut in small cubes, fixed for 5 h at room temperature in 2 % paraformaldehyde (Merck) and 0.5% glutaraldehyde (Merck) in 0.1 M phosphate buffer, and then rinsed overnight in the same buffer. The next day, tissues were dehydrated through graded ethanols at decreasing temperatures, up to -35"C in a LTE 020 Balzers apparatus (Balzers Union, Vaduz, Liechtenstein) and maintained at this temperature all through the subsequent infiltrations in Lowicryl K4M resin (Chemische Werke Lowi, Waidkraiburg, FRG). Polymerization was carried out in UV light first at -35°C for 24 h, and then at room temperature for additional 48 h. Representative regions of the tissues were selected on semithin sections and cut in thin sections which were collected on Formvarcoated nickel grids covered by a carbon film. The grids were first incubated for 30 rain at room temperature in PBS (150 m_M NaC1 in 10 mM phosphate buffer, pH 7.2) containing 5% normal goat serum (Aurion, Wageningen, The Netherlands), 0.8% BSA (Fluka Chemie AG) and 0.1% gelatin (Cold Water Fish Skin gelatin 40%; Aurion), and then for 2 h on drops of anti-a-SM-1 diluted at 1:10 in PBS containing 1% normal goat serum, 0.8% BSA, and 0.1% gelatin, and then rinsed three times for 10 rain in PBS containing BSA and gelatin. The second incubation was performed with goat anti-mouse IgG conjugated to 0.8-nm gold particles (GP-Ultra Small; Aurion) diluted at 1:100 in PBS containing normal goat serum, BSA, and gelatin for 2 h at room temperature. They were rinsed three times for 15 rain in PBS containing BSA and gelatin, three times for 5 rain in PBS, and finally rinsed in sterile distilled water. Amplification of the gold staining was performed by reaction with colloidal silver (Aurion) for 15 rain at room temperature according to Danscher (1981) . Grids were counterstained with uranyl acetate and lead citrate and examined in a Philips 400 electron microscope.
SDS-PAGE and Immunoblotting
For SDS-PAGE, cells were trypsinized and, after haemocytometer cell counts, were mixed in buffer containing 1% SDS (Bio-Rad Laboratories AG), 1% DTT (Fluka Chemic AG), 1 mM PMSF (Merck), 1 mM Nc~-PTosyl-L-arginine methylester (Sigma Immuncchemicals) in 0.4 M Tris HCI, pH 6.8 (Laemmli, 1970) . The samples were immediately sonicated and boiled for 3 rain. Protein content was determined according to Bradford (1976) . 40/~g protein was electrophoresed on a 5-20% gradient gel and stained with Coomassie blue. For quantification of total actin, gels were scanned with a computerized laser beam densitometer (Genofit SA, Geneva, Switzerland) as previously described (Kocher et al., 1985; Desmouli~re et al., 1991) .
Western blotting with anti-ccSM-l, a mouse rnAb-specific for ~-SM actin, was performed according to Skalli et al. (1986) . Briefly, 5 to 20 tLg protein were electrophoresed on a 5-20% gradient gel. Separated proteins were transferred to nitrocellulose filters (Towbin et al., 1979) which were incubated with anti-ccSM-l. A second incubation was done with a rabbit anti-mouse IgG conjugated with HRP (Nordic Immunological Laboratories). Enhanced chemiluminescence (Amersham International pie, Buckinghamshire, England) was used for detection.
RNA Extraction and Northern Blot Hybridization
Cultured cells were scraped from Petri dishes using a rubber policeman and homogenized in a sterile solution, pH 7.4, containing 4.5 M guanidine isothioeyanate (Fluka Chemie AG), 50 mM EDTA (Fluka Chemie AG), 0.1 M fl-mercaptoethanol (Fluka Chemie AG), 25 mM sodium citrate (Merck) and 2% N-lauroylsarcosine (Sigma Immunochemicals) with a sytinge through a 23-gauge needle as previously described (Koeher and Gabbiani, 1987) . RNA was purified by ultracentrifugation through a cushion of 5.7 CsCI (Chirgwin et al., 1979) . The RNA pellets were resuspended in 10 mM Tris HCI, pH Z4, 0.5% SDS (Bio-Rad Laboratories AG) and 1 mM EDTA (Fluka Chemie AG), extracted twice with saturated phenolchloroform, and then once with chloroform-isoamylalcohoi (24:1, vol/vol). The RNA was ethanol precipitated, resuspended in sterile water, and stored at -70"C.
Samples (5-20/~g) of total RNA were denatured with glyoxal, separated by eleetrophoresis in a 1% agarose gel, and then transferred overnight on a Hybond-N filter (Amersham Corp.). Next day, the membrane was baked for 2 h at 80"C under vacuum and stained with 0.04% methylene blue in 0.5 M Na-acetate to verify correct loading and transfer. Hybridization was performed with a riboprobe derived from the coding region of the rat a-SM actin mRNA which recognizes all actin mRNAs (total actin probe pRAoaA-C; K.ocher and Crabbiani, 1987) or with synthetic oligonucleotides specific either for rat a-SM actin (Bochaton-Piallat et al., 1992) or for human a-SM actin (Barret and Benditt, 1987) mRNAs respectively. For the riboprobe, 32P-labeling was carried out aceordin~g to Melton et al. (1984) and Northern blot hybridization was performed as previously described (Kocher and Gabbiani, 1987) with minor modifications. The Northern blots were washed twice for 20 min at 58°C in 3× SSC and 2x Denhardt's solution (Sambrook et al., 1989) , and subsequently three times in 0.2× SSC, O. 1% SDS (Bio-Rad Laboratories AG), and 0.1% Na-pyrophospbate, pH 7.0, for 20 rain at 70"C. s2P-labeling of the oligonucleotides and hybridization were performed according to Sambrook et al. (1989) . Filters were exposed to Kodak X-Omat SO-282 film at -70"C between intensifying screens and developed films were analyzed by means of computerized densitometric scanning (Desmouli~re et al., 1991; Bochaton-Piallat et al., 1992) .
Results

Effect of TGFfJl In Vim
7 d after implantation, the reactive connective tissue around all pumps appeared macroscopically as a capsule, and was always distinct from the non-reactive subcutaneous tissue (Desmouli~re et al., 1992b) . In controls, the pumps remained mobile and the capsule was very thin. In animals treated with TNFo~, the capsules were adherent to the subcutaneous tissue and clearly thicker than the control capsule. In animals treated with TGFfll, the capsules were adherent to the subcutaneous tissue and less thick than those induced by TNFa.
At light microscopic examination, the newly formed capsules had different features according to the treatment. Tissue surrounding control pumps consisted of fibroblasts, new blood vessels, and extracellular matrix accompanied by a very weak inflammatory reaction. After TNFe~ treatment, a typical granulation tissue was observed; in addition, mononuclear cells and few polymorphonuclear cells were present, particularly close to the surface facing the osmotic pump (Desmouli~re et ai., 1992b). With TGFfll, pronounced neovascularization and extensive collagen deposits surrounding fibroblastic cells were seen; leucocyte infiltration was mild.
After immunofluorescence staining, the walls of arterioles, venules and capillaries were positive for ,-SM actin and desmin (Fig. 1) , as well as for SM myosin. In fibroblastic cells of capsules surrounding pumps delivering NaCI and TNFu (Fig. 1, a and b) , c~-SM actin and desmin stainings were never detected. In the presence of TGF~ (Fig. 1 c) , a diffuse positive staining for a-SM actin was observed in each animal; the cellular staining was often clearly distributed in bundles and most pronounced in the tissue portion close to the pump. A weak but definite staining for desrain was also observed (Fig. 1 d) .
By in situ hybridization with the ot-SM actin probe a high labeling was localized on the vessel walls, particularly in arterioles, of subcutaneous tissue (Fig. 2 a) . In granulation tissue, autoradiographic silver grains were diffusely distributed at a high density compared to the adjacent unaffected subcutaneous tissue (Fig. 2 b) . Densitometric analysis showed that in o~-SM actin expressing granulation tissue and in vessel wails, OD values were increased to 172 + 3 % (P < 0.001) and 217 + 3% (P < 0.001), respectively, compared to the levels of the subcutaneous tissue.
EM showed that fibroblasts of control capsules were characterized by a smooth nuclear outline and a cytoplasm rich in RER, Golgi apparatus, and mitochondria. In TNFottreated tissues, in addition to such fibroblasts, several myofibroblastic cells were present showing typical cytoplasmic microfilament bundles or stress fibers (Desmouli~re et al., 1992b) . After TGFfll treatment, stress fibers, often located beneath the plasmalemma and parallel to the main axis of the cell, were present in a large proportion of fibroblastic cells. Dense bodies were scattered within these bundles. Microfilament bundles were also located along cytoplasmic extensions, frequently observed in these myofibroblasts. These cells showed also a dilated RER suggesting their involvement in an active synthetic activity.
Immunogold EM with anti-otSM-1 was performed on TNFo~-and TGFfll-induced capsules. As described previ- ously (Skalli et al., 1989a; Darby et al., 1990) , pericytes were always labeled. TNFc~-induced granulation tissue showed fibroblastic cells containing microfilament bundles not decorated (Fig. 3 a) or decorated by few gold granules (Desmouli~re et al., 1992b) . In granulation tissue induced by TGF/~I, practically all myofibroblasts were stained with anti-otSM-1 with many colloidal silver particles localized over extensive stress fibers (Fig. 3 b) .
Effect of TGF{31 on Cultured Fibroblasts
In 10% FCS and 10% WBS, we observed an antiproliferative effect of TGF/ffl (10 ng/ml, 65.1 + 1.3% and 40.1 ± 2.2% of control conditions).
Immunoblot analysis showed that the expression of ot-SM actin was increased in the presence of TGF/~I when human subcutaneous fibroblasts were cultured in medium plus 10% FCS (Fig. 4, a-d) or 10% WBS. This increase was higher when TGF/~I was added to sparse subconfluent cells compared to confluent growth-arrested cells (data not shown). Moreover, an increase of o~-SM actin expression by TGF~I treatment was observed in fibroblasts cultured in PDS (Fig. 
4, e-h).
A dose-response study with a confluent culture of human subcutaneous fibroblasts ("~3 x 106 cells per 100 mm Petri dish) showed that TGF~I was able to induce a-SM actin expression at a dose of 1 ng/ml (8 ml per Petri dish). By densitometric scanning of Western blots, values expressed as percentage of the 10% PDS value were 380 for 10 ng/ml, 430 for 5 ng/ml, 330 for 2 ng/ml, and 270 for 1 ng/ml (standard errors of means were always <5 % of the values).
Quantitative changes of total actin content were examined by densitometric analysis of SDS-PAGE (Fig. 4, a, b , e, and f ) . Total actin contents were similar in 10% FCS and 10% PDS cultured fibroblasts. T G F~ treatment did not modify significantly the total actin content which was 13.8 ± 0.4% of total cellular protein in subcutaneous adult rat fibroblasts, and 12.7 ± 0.3% in human subcutaneous fibroblasts.
Immunofluorescence studies (Fig. 5) showed that the increase of ot-SM actin expression by TGFfiq treatment in human subcutaneous fibroblasts cultured in PDS was at least in part due to a significant increase in the percentage of ot-SM actin positive cells (45.3 + 2.1%) compared to control cells (7.5 -1-0.8%, P < 0.001). No significant modifications concerning the number of desmin-positive cells (<10%) or the number of SM myosin positive cells (<15%) were observed. When fibroblasts were treated by TGF/31 (10 ng/ml or less) in the presence of 10% PDS, we never observed cell death as previously described for cultured SM cells (Bj6r-kerud, 1991) .
We examined also the influence of FCS, WBS, and PDS on the expression of ot-SM actin in cultured human fibroblasts. An increase oftx-SM actin expression was observed in the presence of 1% serum (FCS or WBS) compared to 10% serum. Densitometric scanning of Western blots showed that in fibroblasts cultured in the presence of 1% WBS, the level of ot-SM actin expression was clearly increased compared to the value obtained for fibroblasts cultured in 10% WBS (Fig.   6 ). Neutralizing antibodies to TGF/~I abolished the increase of ot-SM actin expression observed in 10% PDS plus 1 ng/ml TOF/~I. Moreover, preincubation of medium containing 10% WBS (inducing cell replication) or 1% WBS (maintaining fibroblasts quiescent with high levels of c~-SM actin) with neutralizing antibodies to T G F~ resulted in a decrease of a-SM actin expression in both 10% WBS ( P < 0.01) and 1% WBS (P < 0.001, Fig. 6 ). When neutralizing antibodies to TGF/~I were incubated with medium containing PDS, no changes in the expression of o~-SM actin were observed compared to controls.
A marked increase of a-SM actin expression by TGF/5'I was also observed in HFL-1 cells. By densitometric scanning of Western blots, values expressed as percentage of the 10 % FCS value were 3,070 for 5 ng/ml, 2,740 for 2 ng/ml, and 2,070 for 1 ng/ml. In these culture conditions, no effect was observed with a dose of 0.1 ng/ml. Cultured bovine aortic endothelial cells did not express ot-SM actin normally and upon treatment with TGF/31.
Hybridization with the total actin probe pRAootA-C of total RNA preparations from human subcutaneous fibroblasts resulted in two bands corresponding to fl-+ 3'-(2.1 kb) and ct-(1.7 kb) actin mRNAs (Kocher and Gabbiani, 1987) . In cells cultured in 10% PDS and treated with TGF/~I (5 ng/ml) for 7 d, the 1.7-kb band was markedly increased compared to control cells. An induction of the 2.1-kb band was also observed (Leofet al., 1986) . Densitometric scanning of North- ern blots hybridized with the total actin probe showed that after TGF/31 treatment, total actin mRNA was increased to 215 + 3% of the level of controls. Densitometric scanning of Northern blots hybridized with our specific oligonucleotide showed that after TGFB1 treatment, a-SM actin mRNA was increased to 380 + 2% of the level of controls (Fig. 7) . Similar results showing an important action of TGFB1 on a-SM actin mRNA expression were also obtained in rat fibroblasts (data not shown).
D i s c u s s i o n
Many morphological and functional features of the myofibroblast have been recently defined (for review see Schiirch et al., 1992) . Thus, it is established that during the modulation from fibroblast to myofibroblast, this cell acquires the expression of o~-SM actin and, albeit more rarely, of desmin (Skalli et al., 1989b) , but almost never of SM myosin heavy chains (Benzonana et al., 1988; Eddy et al., 1988) . There is a correlation between the expression of these SM cell markers by myofibroblastic cells and the presence of an active retractile fibrosis in the affected tissues (Darby et al., 1990; Schmitt-Griiff et al., 1991) . Myofibroblasts are also considered to be responsible, at least in part, for the production of connective tissue matrix components which characterizes fibrotic situations (Ramadori et al., 1987; Schiifer et al., 1987; Skalli and Gabbiani, 1988) 1985). The problem of the origin of myofibroblasts has not been yet fully clarified. It has been suggested that myofibroblasts of wounds arise locally from quiescent fibroblasts (Darby et al., 1990 ) but they may also originate from more specialized cells such as perisinusoidal cells in the liver (Ballardini et al., 1988; Ramadori, 1991; Schmitt-Gr~iff et al., 1991) , mesangial cells in the glomerulus (Johnson et al., 1991) , interstitial cells in the lung septa (Mitchell et al., 1989; Kapanci et al., 1990; Kuhn and McDonald, 1991) , and perivascular SM cells (Shum and McFarlane, 1988 ; for a detailed review on this subject see Schiirch et al., 1992) . All these observations support the view that, whatever the origin, myofibroblastic modulation is an important step in wound healing and in pathological phenomena characterized by tissue retraction and fibrosis. However, little is known about the factors regulating on one hand the differentiation and the disappearance of myofibroblasts and on the other hand their functional activities. We show here that TGFfll stimulates in vivo the modulation of fibroblasts into ot-SM actin expressing myofibroblasts. It has been recently reported that wounds in adult rats treated with a neutralizing antibody to TGF/3 presented a reduced inflammatory response and restitution of the dermal architecture without scarring, thus suggesting that TGFfl plays a role in wound retraction and scar formation in vivo (Shah et al., 1992) . Moreover, inhibition of TGFfl by decorin significantly reduced scarring in an experimental model of glomerulonephritis .
When several growth factors were tested in vivo for their capacity to generate ot-SM actin rich myofibroblasts, it was observed that interleukin-1 (IL-1), PDGF, and TNFc~ did not possess the capacity of inducing ot-SM actin expression, which however was exerted by granulocyte macrophagecolony-stimulating factor (GM-CSF). GM-CSF activity is allegedly indirect since this cytokine, differently from TGFfll, had no effect on ot-SM actin expression on cultured fibroblasts . After GM-CSF local application, the appearance of ot-SM actin-rich myofibroblasts is preceded by an accumulation of macrophage clusters (Vyalov et al., 1993) which conceivably could produce one or more ot-SM actin expression inducing factors, among which TGFfll is a likely candidate. In the same work (Rubbia-Brandt et al., 1991), we had described that TGFfl has no action of a-SM actin expression in vivo: since our present results have been repeatedly obtained with TGFfll isolated from human platelets supplied by two sources (see Materials and Methods) and with recombinant TGFfll, we assume that TGFfll used for the previous experiment was contaminated by a substance inhibiting ot-SM actin expression. Work is in progress in our laboratory to identify this contaminant.
We have also recently reported (Desmouli~re et al., 1992b ) that heparin stimulates the expression of a-SM actin in fibroblastic cells, both in vivo and in vitro. However, heparin acts only when fibroblasts undergo replication, suggesting that it produces a selection of ot-SM actin-positive cells rather than an activation of the et-SM actin gene. It has been shown that heparin potentiates the biological action of TGFfl (McCaffrey et al., 1989 (McCaffrey et al., , 1992 . Indeed many similarities exist between the action of heparin or heparin-like molecules and TGF/~ particularly on cell proliferation and extracellular matrix synthesis (McCaffrey et al., 1992) .
In addition to its action in vivo, our results show that TGF/$1 stimulates de novo the synthesis of ot-SM actin in cultured fibroblasts growing in the presence of 10% FCS as well as in quiescent fibroblasts after confluence in the presence of 10% FCS or subconfluent in the presence of PDS. In this last case, the percentage of fibroblasts expressing a-SM actin was increased about six times compared to controls. We do not know whether TGFfll induces the transcription of ot-SM actin mRNA or modifies the degradation of such mRNA in a cell which already expresses it. Further studies are necessary to clarify this point. In any event it appears that TGF~I is up to now the only substance known to be capable of stimulating c~-SM actin synthesis in cultured quiescent fibroblastic cells. TGF/3 increases also the expression of ct-SM actin in cultured SM cells (BjOrkerud, 1991) . We have previously shown that a population of cultured fibroblasts always contains a subpopulation of a-SM actin positive cells, even after cloning, suggesting that the expression of ot-SM actin is a constitutive feature of a fibroblast population in vitro, where serum and hence TGF/~ are present (Desmouli~re et al., 1992a) . TGFfl could represent one of the main regulators of this fibroblastic feature. This is supported by the observation that incubation of medium containing exogenous TGFfll in addition to PDS as well as of medium containing WBS, but not of medium containing only PDS with neutralizing antibodies to TGFfll reduces significantly the expression of a-SM actin in both replicating and quiescent fibroblasts. It remains to be established if and how TGFfl modulates the fibroblastic phenotype in vivo during wound healing. We suggest that during this phenomenon, fibroblast replication and movement as well as stress fiber formation (resulting in myofibroblasts without o~-SM actin [for a discussion of the heterogeneity of myofibroblastic phenotype see Sappino et al., 1990b] ) are under the control of factors other than TGFfl. This cytokine could play a role subsequently by stimulating collagen and a-SM actin synthesis and thus allowing the formation of a typical granulation tissue with ot-SM actin-rich myofibroblasts, such as seen in rats 8 to 15 d after an experimental wound (Darby et al., 1990) .
The study of growth factor and cytokine activities has allowed an important progress in the understanding of wound healing mechanisms (Deuel et al., 1991; Kovacs, 1991; Robson, 1991; Pierce et al., 1991 Pierce et al., , 1992 . We know that many growth factors and cytokines are capable of stimulating fibroblast replication in vitro (Chert and Rabinovitch, 1990; Thornton et al., 1990; Kumar et al., 1991) and in vivo Desmouli&e et al., 1992b) , collagen synthesis in vitro (Roberts et al., 1986) and fibrosis formation in vivo (Krummel et al., 1988; Kovacs, 1991) . However, with the exception of TGFfl, these growth factors do not affect directly ~-SM actin expression by fibroblasts , hence they presumably are not responsible for the differentiation of typical myofibroblastic cells. Extracellular matrix components are also capable of modifying the phenotype and the functional features of fibroblasts (Gospodarowicz et al., 1980; Kao et al., 1984; Desmouli~re et al., 1992b) . However the only extracellular matrix component capable of intluencing ot-SM actin expression in these cells, i.e., heparin, acts by selecting ot-SM actin-positive cells among replicating fibroblasts (Desmouli~re et al., 1992b) .
It is well established that TGFfl plays a role in the differen- Our results may help in the understanding of the mechanisms involved in the production and control of granulation tissue and are in accordance with the possibility that, at least in certain cases, cell differentiation is not controlled by genetically irreversible steps, as it has been assumed for a long time, but is modulated locally by microenvironmental influences exerted by cytokines, growth factors and extracellular matrix components (Blau and Baltimore, 1991).
